TSS
SONM icon

Two Sigma Securities’s DNA X Inc SONM Stock Holding History

Two Sigma Securities’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,085
Closed -$45.8K – 1954
2025
Q2 		$45.8K Buy
+2,085
New +$51.4K 0.01% 1121
2024
Q3 		– Sell
-213
Closed -$38.3K – 3572
2024
Q2 		$38.3K Buy
+213
New +$23.2K ﹤0.01% 2605
2024
Q1 		– Sell
-176
Closed -$23.2K – 3597
2023
Q4 		$23.2K Buy
176
+92
+110% +$12.2K ﹤0.01% 2700
2023
Q3 		$10.1K Buy
+84
New +$11.7K ﹤0.01% 2694
2022
Q4 		– Sell
-79
Closed -$7K – 3213
2022
Q3 		$7K Buy
+79
New +$9.81K ﹤0.01% 2448
2022
Q2 		– Sell
-113
Closed -$17K – 2805
2022
Q1 		$17K Sell
113
-121
-52% -$16.4K ﹤0.01% 1999
2021
Q4 		$39K Buy
+234
New +$71.1K ﹤0.01% 1313
2021
Q1 		– Sell
-30
Closed -$40K – 1641
2020
Q4 		$40K Buy
+30
New +$32.8K ﹤0.01% 1570

Other funds holding SONM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

Two Sigma Securities's SONM Position: Q3 2025 in Review

Two Sigma Securities sold out of DNA X Inc (SONM) in Q3 2025, closing a stake of 2,085 shares — an estimated $45.8K sold.

Two Sigma Securities first reported a position in SONM in Q4 2020 and held it in 8 quarters. The position peaked at $45.8K in Q2 2025. 12 funds tracked by Wall St. Rank hold SONM as of Q3 2025.

  • Two Sigma Securities reported no remaining DNA X Inc position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,085 DNA X Inc shares in Q3 2025, an estimated $45.8K.
  • Two Sigma Securities first reported a position in DNA X Inc in Q4 2020 and held it in 8 quarters.
  • Two Sigma Securities's DNA X Inc position peaked at $45.8K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.